HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE

MBL Life Sciences

Catalog No.: MBL-TC-0155-1

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: PE
• Immunogen: survivin
• Peptide Sequence: LTLGEFLKL
• Class: Class I
• Sequence Location: 96-104
• MHC Allele: A*02:01